home / stock / dxcm / dxcm news


DXCM News and Press, DexCom Inc. From 04/25/24

Stock Information

Company Name: DexCom Inc.
Stock Symbol: DXCM
Market: NASDAQ
Website: dexcom.com

Menu

DXCM DXCM Quote DXCM Short DXCM News DXCM Articles DXCM Message Board
Get DXCM Alerts

News, Short Squeeze, Breakout and More Instantly...

DXCM - DexCom, Inc. (DXCM) Q1 2024 Earnings Call Transcript

2024-04-25 19:36:08 ET DexCom, Inc. (DXCM) Q1 2024 Earnings Conference Call April 25, 2024 4:30 p.m. ET Company Participants Sean Christensen - Vice President of Finance, and Investor Relations Kevin Sayer - Chairman, President, and Chief Executive Officer Jereme...

DXCM - Dexcom down 7% after hours despite quarterly beats, 2024 outlook updates

2024-04-25 19:27:21 ET More on DexCom DexCom, Inc. 2024 Q1 - Results - Earnings Call Presentation DexCom Is Pricey For A Reason - Its Growth Story Reflects That DexCom: A Wealth Compounder In Healthcare DexCom Non-GAAP EPS of $0.32 beats by $0.05, revenue of ...

DXCM - DexCom Non-GAAP EPS of $0.32 beats by $0.05, revenue of $921M beats by $10.1M

2024-04-25 16:05:05 ET More on DexCom DexCom Is Pricey For A Reason - Its Growth Story Reflects That DexCom: A Wealth Compounder In Healthcare DexCom, Inc. (DXCM) Q4 2023 Earnings Call Transcript DexCom Q1 2024 Earnings Preview DexCom started at outpe...

DXCM - Dexcom Reports First Quarter 2024 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an organic 1 basis. U.S. ...

DXCM - Ithaka Group Q1 2024 U.S. Growth Commentary

2024-04-25 10:45:00 ET Summary The Ithaka Group is an independent investment boutique that specializes in managing high-quality, concentrated growth equity portfolios. The first quarter of 2024 saw a decoupling of the relationship between bond yields and equities, with the S&P...

DXCM - Expected US Company Earnings on Thursday, April 25th, 2024

Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...

DXCM - DexCom Q1 2024 Earnings Preview

2024-04-24 17:20:12 ET More on DexCom DexCom Is Pricey For A Reason - Its Growth Story Reflects That DexCom: A Wealth Compounder In Healthcare DexCom, Inc. (DXCM) Q4 2023 Earnings Call Transcript DexCom started at outperform at RBC on diabetes total addressab...

DXCM - Top high growth investment ratio stocks from each sector - GS

2024-04-22 16:25:01 ET More on S&P 500 Index: Why AI Stocks Could Go Boom Fed's Commercial Banking Report Shows Economic Headwinds, But Deposit Growth Bucks Trend S&P 500: Capitulation? Week Starting 22nd April (Technical Analysis) Nasdaq, S&P, an...

DXCM - Trading (DXCM) With Integrated Risk Controls

2024-04-20 23:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

DXCM - Portfolio Review: The Cat, The Tortoise And Me

2024-04-15 02:54:24 ET Summary I created two dummy portfolios for a giant tortoise and a cat to provide context for my articles. The first quarter of the year is ending, prompting a swift evaluation of the evolution, results, metrics, critique style, and unresolved points of these...

Previous 10 Next 10